Pino R Z, Feelisch M
Department of Nitric Oxide Research, Schwarz Pharma AG, Monheim, FRG.
Biochem Biophys Res Commun. 1994 May 30;201(1):54-62. doi: 10.1006/bbrc.1994.1668.
Nitroxyl (NO-) is the one-electron reduction product of nitric oxide (NO.). Recently, NO- generating compounds were shown to possess potent vasorelaxant activity and this was attributed to the ready conversion of NO- to NO.. Because of its metastable character, direct chemical detection of NO- or its conjugated acid, HNO, has not been accomplished yet. In order to gain further insight into the cellular mode of action of NO- generating compounds we aimed at finding a means to discriminate NO- from NO. by bioassay. Using isolated rat aortic rings in organ baths, we here show that high concentrations of L-cysteine cause complete inhibition of the vasorelaxant response to NO- (generated from Angeli's salt and sodium nitroxyl) whereas responses to authentic NO. and S-nitrosocysteine are largely enhanced. Preliminary results indicate that the inhibition by L-cysteine of NO- activity may be mediated in part by enzymatic and non-enzymatic mechanisms. Whether or not NO- generating compounds will have promising therapeutic potential as a new class of NO.- donors will not least depend on their interference with enzymatic routes susceptible to inhibition by NO-.
硝酰阴离子(NO⁻)是一氧化氮(NO·)的单电子还原产物。最近,已证明产生NO⁻的化合物具有强大的血管舒张活性,这归因于NO⁻能迅速转化为NO·。由于其亚稳态特性,尚未实现对NO⁻或其共轭酸HNO的直接化学检测。为了进一步深入了解产生NO⁻的化合物的细胞作用模式,我们旨在找到一种通过生物测定法区分NO⁻和NO·的方法。在器官浴中使用分离的大鼠主动脉环,我们在此表明高浓度的L-半胱氨酸会完全抑制对NO⁻(由安吉利盐和硝酰钠产生)的血管舒张反应,而对纯NO·和S-亚硝基半胱氨酸的反应则大大增强。初步结果表明,L-半胱氨酸对NO⁻活性的抑制可能部分由酶促和非酶促机制介导。作为一类新的NO·供体,产生NO⁻的化合物是否具有有前景的治疗潜力,将至少部分取决于它们对易受NO⁻抑制的酶促途径的干扰。